Center for Biodefense and Emerging Infectious Disease was created in 2002, and is a consolidation of the Center for Tropical Diseases and the Center for Biodefense. The main goal of the CBEID is to support the mission of the Institute for Human Infections and Immunity (IHII) by coordinating activities and research involving infectious agents, particularly emerging infectious diseases and agents of bioterrorism.
Institute for Human Infection and Immunity is breaking new ground in understanding the nature of infectious diseases, and is working to translate new research concepts into products aimed at controlling emerging infectious diseases and mitigating their effects on society. It's mission is to coordinate, facilitate and enhance the activities of UTMB’s research centers and programs that focus on advancing the fields of infection and immunity.
Sealy Institute for Vaccine Sciences was inaugurated in December, 2001. With 69 faculty members, the center incorporates the expertise of more than 100 cutting edge research programs currently at UTMB. These newly formed relationships, as well as collaborative relationships with investigators elsewhere, will help us translate laboratory findings to the bedside and beyond.